Salter Brothers eyeing small cap medtechs
Salter Brothers – which specialises in alternative assets – sees great potential in these three ASX-based medtechs, both for patients and investors. Today we hear from Salter Brothers director of equities and portfolio manager Gregg Taylor. Firstly a little bit about Salter Brothers, which is a $3 billion alternative asset manager in Australia. The fund … [Read more…]